Alkyl Amines Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2025.
ALKYLAMINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 2.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Alkyl Amines Chemicals approved audited financial results for Q4 and FY ended March 31, 2025, with the statutory auditor issuing a clean (unmodified) opinion. Revenue from operations rose to Rs. 1,571.82 Cr in FY25 from Rs. 1,440.61 Cr in FY24, a growth of about 9%. Profit after tax (PAT) jumped to Rs. 186.14 Cr from Rs. 148.87 Cr, a growth of roughly 25%, with EPS rising to Rs. 36.40 from Rs. 29.13. The Board recommended a final dividend of Rs. 10 per share (500% on face value of Rs. 2) for FY25, subject to shareholder approval. Additionally, Aneja Assurance was appointed as Internal Auditor for 3 years and P. Mehta & Associates as Secretarial Auditor for 5 years. Operating cash flow remained healthy at Rs. 263.10 Cr.
Strong profit growth and a generous 500% dividend reflect robust financial health and shareholder-friendly capital allocation, which should be viewed positively by investors. The clean audit opinion and stable auditor appointments reinforce governance confidence, though the absence of revenue growth above 20% tempers the scale of the operational outperformance.